HIGHLIGHTS
- What: The authors aimed to identify factors associated with FC, time to treatment, and survival outcomes in patients with breast cancer. The authors explore the independent effects on survival according to treatment delay and FC. Lastly, compared to the work by Gamboa et_al which described increased mortality experienced by breast cancer patients receiving FC in Colombia, the study designs and patient populations are quite dissimilar which could explain variability in the results of these two studies.
- Who: Hadley D. Freeman from the Division of Surgical Oncology, Department of Surgery, Loma Linda University, Loma Linda, CA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.